HONG KONG – Preoperative atrial natriuretic peptide (ANP) improved survival in lung cancer patients undergoing surgery and appeared to prevent cancer metastasis through prevention of vascular endothelial inflammation and adhesion in mice, Japanese researchers reported in the March 16, 2015, early edition of the Proceedings of the National Academy of Sciences.